Researchers detected cancer-linked genetic mutations in blood samples taken over three years before diagnosis. In a ...

A highly transmissible new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading in the United States, CDC data show.

The model enables the study of the fundamental interactions that underlie neurodegenerative disease. Researchers from Northwestern University and the University of California, Santa Barbara have ...

Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to ...

QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular ...

In mice, engineered immune cells shrink pancreatic and other tumours bearing a mutant version of the KRAS protein.

AstraZeneca's camizestrant and Pfizer's vepdegestrant extended progression-free survival in trials in advanced ESR1-mutated breast cancer.

This mutation in the PIK3CA gene causes cells to divide and replicate uncontrollably. More than half of the patients in the trial had metastatic breast cancer that had spread to three or more ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and fulve ...